The Pfizer-backed Series C round will see Storm work out an accelerated approval pathway for STC-15 in sarcoma.
Efforts to improve cancer imaging technologies are crucial for diagnosing and treating the disease effectively. This transition from experimental to clinical use requires bridging the gap between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results